ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹159 Cr | ₹98 Cr | ₹69 Cr | ₹74 Cr | ₹45 Cr |
What is the latest Total Non-Current Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹159 Cr |
| Mar2024 | ₹98 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹74 Cr |
| Mar2021 | ₹45 Cr |
How is Total Non-Current Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹159 Cr | 62.66 | |
| Mar2024 | ₹98 Cr | 41.80 | |
| Mar2023 | ₹69 Cr | -6.30 | |
| Mar2022 | ₹74 Cr | 65.09 | |
| Mar2021 | ₹45 Cr | - | |
Compare Total Non-Current Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹23,028.8 Cr | 1.7% | 0.4% | 39.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.2% | 7.1% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | 0.8% | -6% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 1.2% | 6.4% | 13.1% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.2% | 1.4% | -0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.2% | 5.8% | 4.2% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | 1.7% |
0.4% |
39.3% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses